JAMVX | VMVAX | JAMVX / VMVAX | |
Total Expense Ratio | 0.93 | 0.07 | 1,329% |
Annual Report Gross Expense Ratio | 0.93 | 0.07 | 1,329% |
Fund Existence | 22 years | 14 years | - |
Gain YTD | -7.497 | 3.860 | -194% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 115M | 31B | 0% |
Annual Yield % from dividends | 0.83 | 2.22 | 37% |
Returns for 1 year | -3.45 | 8.49 | -41% |
Returns for 3 years | 8.42 | 21.50 | 39% |
Returns for 5 years | 29.30 | 64.58 | 45% |
Returns for 10 years | 12.21 | 87.40 | 14% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FDVKX | 12.50 | 0.09 | +0.73% |
Fidelity Value Discovery K6 | |||
FTCWX | 13.90 | 0.01 | +0.07% |
Fidelity Advisor Asset Manager 20% C | |||
RYMVX | 72.40 | -0.31 | -0.43% |
Rydex S&P MidCap 400 Pure Value A | |||
BBMIX | 11.51 | -0.06 | -0.52% |
BBH Select Series - Mid Cap I | |||
GTMTX | 22.00 | -0.17 | -0.77% |
Goldman Sachs Small/Mid Cap Growth Inv |